A new trading day began on November 20, 2023, with Singular Genomics Systems Inc (NASDAQ: OMIC) stock priced at $0.451, down -7.27% from the previous day of trading. During the day, the shares moved up to $0.451 and dropped to $0.3944 before settling in for the closing price of $0.44. OMIC’s price has ranged from $0.31 to $3.00 over the past 52 weeks.
Meanwhile, its annual earnings per share averaged 1.59%. With a float of $42.13 million, this company’s outstanding shares have now reached $71.85 million.
The firm has a total of 275 workers. Let’s measure their productivity. In terms of profitability, gross margin is -791.63, operating margin of -12220.52, and the pretax margin is -11879.61.
Singular Genomics Systems Inc (OMIC) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Medical Instruments & Supplies Industry. The insider ownership of Singular Genomics Systems Inc is 42.59%, while institutional ownership is 28.55%. The most recent insider transaction that took place on Nov 17, was worth 31,755. In this transaction Chief Executive Officer of this company bought 75,000 shares at a rate of $0.42, taking the stock ownership to the 4,061,206 shares. Before that another transaction happened on Nov 16, when Company’s Chief Scientific Officer bought 200,000 for $0.43, making the entire transaction worth $85,640. This insider now owns 4,570,000 shares in total.
Singular Genomics Systems Inc (OMIC) Earnings and Forecasts
In its latest quarterly report, released on 9/29/2023, the company reported earnings of -$0.31 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). This company achieved a net margin of -11879.61 while generating a return on equity of -30.47. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.32 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 1.59% per share during the next fiscal year.
Singular Genomics Systems Inc (NASDAQ: OMIC) Trading Performance Indicators
Here are Singular Genomics Systems Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 12.77. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 11.44.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.28, a number that is poised to hit -0.30 in the next quarter and is forecasted to reach -1.23 in one year’s time.
Technical Analysis of Singular Genomics Systems Inc (OMIC)
Analysing the last 5-days average volume posted by the [Singular Genomics Systems Inc, OMIC], we can find that recorded value of 0.67 million was better than the volume posted last year of 0.33 million. As of the previous 9 days, the stock’s Stochastic %D was 34.91%. Additionally, its Average True Range was 0.06.
During the past 100 days, Singular Genomics Systems Inc’s (OMIC) raw stochastic average was set at 12.88%, which indicates a significant decrease from 29.59% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 216.58% in the past 14 days, which was higher than the 94.77% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.3850, while its 200-day Moving Average is $0.9231. Now, the first resistance to watch is $0.4395. This is followed by the second major resistance level at $0.4735. The third major resistance level sits at $0.4961. If the price goes on to break the first support level at $0.3829, it is likely to go to the next support level at $0.3603. Should the price break the second support level, the third support level stands at $0.3263.
Singular Genomics Systems Inc (NASDAQ: OMIC) Key Stats
With a market capitalization of 29.75 million, the company has a total of 73,385K Shares Outstanding. Currently, annual sales are 770 K while annual income is -90,880 K. The company’s previous quarter sales were 510 K while its latest quarter income was -25,580 K.